These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9100473)

  • 1. HIV update.
    Schmidt ME
    Va Med Q; 1997; 124(2):105-7. PubMed ID: 9100473
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes virus infections, HIV, and disease progression. Recommended, not required.
    Cotton D
    AIDS Clin Care; 1995 Feb; 7(2):15. PubMed ID: 12212539
    [No Abstract]   [Full Text] [Related]  

  • 3. Simulation of the San Francisco HIV epidemic: AZT a possible epidemiological modulator.
    Lee L; Saltzberg AM; MacRae D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):207-8. PubMed ID: 7552489
    [No Abstract]   [Full Text] [Related]  

  • 4. AZT in Africa.
    Kottow MH
    J Clin Ethics; 1999; 10(2):166-7. PubMed ID: 10633289
    [No Abstract]   [Full Text] [Related]  

  • 5. A review and update on HIV infection and the AIDS epidemic in the adolescent and adult.
    Kahn MA
    J Tenn Dent Assoc; 2000; 80(4):21-7. PubMed ID: 11323867
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV infection in women and children].
    Giaquinto C
    Epidemiol Prev; 1996; 20(2-3):131-2. PubMed ID: 8766298
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy.
    Gómez-Cano M; Soriano V; Pérez-Olmeda M; Machuca A; Rodríguez-Rosado R; Valencia E; Moreno V; Gutiérrez M; González-Lahoz J
    AIDS; 1998 May; 12(8):964-6. PubMed ID: 9631158
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV management update.
    Hamada OL
    Am Fam Physician; 1997 Dec; 56(9):2186, 2188. PubMed ID: 9402807
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
    Mildvan D; Bassiakos Y; Zucker ML; Hyslop N; Krown SE; Sacks HS; Zachary J; Paredes J; Fessel WJ; Rhame F; Kramer F; Fischl MA; Poiesz B; Wood K; Ruprecht RM; Kim J; Grossberg SE; Kasdan P; Bergé P; Marshak A; Pettinelli C
    Antivir Ther; 1996 Apr; 1(2):77-88. PubMed ID: 11321183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral drugs: new agents, new combinations line up against HIV.
    Phillips L
    Hosp Technol Ser; 1996 Jan; 15(1):1-3. PubMed ID: 10161344
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiretroviral treatment].
    Nielsen HI
    Ugeskr Laeger; 1999 Mar; 161(12):1731. PubMed ID: 10210968
    [No Abstract]   [Full Text] [Related]  

  • 13. Zidovudine monotherapy in pregnancy: is it state of the art?
    Taylor GP; O'Shea S; Mercey D; de Ruiter A
    HIV Med; 2009 Feb; 10(2):129-30; author reply 130-1. PubMed ID: 19200176
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on HIV chemoprophylaxis following exposure.
    Flaxman NA; Reed HS
    J Tenn Dent Assoc; 1997 Oct; 77(4):42-4. PubMed ID: 9520762
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Co-infection with HIV-hepatitis C virus].
    Bertholom C
    Rev Infirm; 2005 Oct; (114):27-8. PubMed ID: 16359042
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance mutations as predictors of phenotypic zidovudine resistance in HIV-1 infection.
    Chen P; Schmit JC; Arendt V; Plesseria JM; Lambert C; Fontaine E; Kirpach P; Ninove D; Schneider F; Hemmer R
    AIDS; 1997 Oct; 11(12):1528-9. PubMed ID: 9342081
    [No Abstract]   [Full Text] [Related]  

  • 18. [Individualization of HIV-therapy].
    Internist (Berl); 1995 Jul; 36(7 Suppl [individu]):1-4. PubMed ID: 9131076
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
    AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
    [No Abstract]   [Full Text] [Related]  

  • 20. [The issue of inhibitors of retroviral infections].
    Govorov VT; Chabanenko AI
    Voen Med Zh; 2003; 324(4):53-5. PubMed ID: 12825369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.